Topics › Labs and treatment targets
Why do we draw these labs, and where do the results go?
HD and PD · Checked 14 Jul to 14 Nov 2026 · One-page sheet for the binder
In short
- The Conditions for Coverage set a clock for only a few labs: Kt/V, hemoglobin, albumin with weight, and hepatitis B tests for in-center HD.1,2
- Iron studies, calcium, phosphate, PTH (parathyroid hormone), hepatitis C and HbA1c follow guideline advice, not requirements. One exception touches payment: a QIP measure scores how many patient-months have a calcium value reported.1,3,4,5,6,7
- A monthly chemistry panel, and routine B12 and folate draws, are house practice: the facility's choice.
- Once your policy writes a schedule down, a surveyor holds you to it.1,2
- Results feed the plan of care and the monthly report to CMS. Some become QIP measures that can lower payment.1,2,7,8,9
How often, and how binding
- Kt/V (HD)1,2: every month, Required
- Weekly Kt/V (PD)1,2: every 4 months, Required
- Hemoglobin or hematocrit1,2: every month, Required
- Albumin and body weight1,2: every month, Required
- HBsAg, susceptible patients1,2: every month, Required
- Anti-HBs, vaccine responders2: every 12 months, Required
- Hepatitis B, chronically infected: no routine test2: no set clock, Required
- Assessment lab profile2: once, at the start, CMS guidance
- Iron: TSAT and ferritin3: every 1 to 3 months, Professional guideline
- Calcium and phosphate4: every 1 to 3 months, Professional guideline
- PTH4: every 3 to 6 months, Professional guideline
- Alkaline phosphatase4: every 12 months, Professional guideline
- Hepatitis C1,5: every 6 months, Professional guideline
- HbA1c (diabetes)6: every 3 to 6 months, Professional guideline
- Lipid panel10: once, at the start, Professional guideline
- Monthly chemistry panel: every month, House practice
- B12 and folate: no set clock, House practice
The detail
The Conditions for Coverage set a clock for only three patient lab measures (dialysis adequacy, hemoglobin, and albumin with body weight), plus hepatitis B testing through a CDC schedule they adopt by reference.1 That adopted schedule binds as written for chronic hemodialysis.1,2 Every other rhythm on a lab calendar comes from guideline bodies or from the facility itself.11 Once drawn, results feed the plan of care and the facility's monthly reporting to CMS, where some become quality measures that can reduce Medicare payment two years later.7,12
- Applies to
- HD and PD
- Checked
- 14 Jul to 14 Nov 2026
- Covers
- The routine lab calendar of a Medicare-certified outpatient facility, HD and PD, and where the results travel
- Doesn't cover
- Orders for an individual patient; state rules; transplant-center testing
Who sets each clock on the lab calendar
One-page sheet for the binder| Draw | What it says | Clock | How much it binds | Applies to | Where it says so | |
|---|---|---|---|---|---|---|
| Required | ||||||
| Kt/V (HD) | Measure delivered Kt/V, or an equivalent measure, for every HD patient. | At least monthlyFrom the first month of treatment and each month after | Requiredregulation, to stay certified | HD (in-center and home) | Where it says so · applies to | |
| Weekly Kt/V (PD) | Measure delivered weekly Kt/V, or an equivalent measure, for every PD patient. | At least every 4 monthsFrom the start of PD and each 4 months after | Requiredregulation, to stay certified | PD | Where it says so · applies to | |
| Hemoglobin or hematocrit | Measure hemoglobin or hematocrit for every patient.“must be measured at least monthly” | At least monthlyFrom admission, then each month | Requiredregulation, to stay certified | HD and PD | Where it says so · applies to | |
| Albumin and body weight | Measure albumin and body weight for every patient.“A patient's albumin level and body weight must be measured at least monthly.” | At least monthlyFrom admission, then each month | Requiredregulation, to stay certified | HD and PD | Where it says so · applies to | |
| HBsAg, susceptible patients | Test hepatitis B-susceptible patients for HBsAg monthly, including those not yet vaccinated, partway through the series, or without an adequate response. Start the vaccine on admission.PD: by facility policy. | Monthly while susceptibleFrom admission | Requiredregulation by incorporation, to stay certified | In-center HD | Where it says so · applies to | |
| Anti-HBs, vaccine responders | Retest vaccine responders for anti-HBs once a year. If it falls below 10 mIU/mL, give a booster and keep retesting annually; retesting right after the booster isn't needed.PD: by facility policy. | AnnuallyFrom a documented vaccine response | Requiredregulation by incorporation, to stay certified | In-center HD | Where it says so · applies toAppendix H (Rev. 246), V127 (CDC text as adopted)Applies to: In-center HD | |
| Hepatitis B, chronically infected: no routine test | The adopted schedule requires no routine follow-up testing of chronically infected patients for infection control; it calls an annual HBsAg reasonable, not required.PD: by facility policy. | None | Requiredregulation by incorporation: the adopted schedule, which sets no routine test here | In-center HD | Where it says so · applies toAppendix H (Rev. 246), V124 (CDC schedule as adopted)Applies to: In-center HD | |
| Once it's in your policy | A house practice written into facility policy has to be followed: the medical director must ensure the policies on admissions, patient care, infection control and safety are adhered to. A surveyor reads your policy against your floor, even where no outside rule set the clock. | None | Requiredregulation, to stay certified | HD and PD | Where it says so · applies to | |
| CMS guidance | ||||||
| Assessment lab profile | The comprehensive assessment includes a laboratory work-up: comprehensive metabolic testing, adequacy, a complete blood count, iron studies and hepatitis B screening. The guidance names what to draw at assessment, not a monthly rhythm. | At each comprehensive assessmentFrom admission (then each reassessment) | CMS guidanceCMS survey guidance | HD and PD | Where it says so · applies toAppendix H (Rev. 246), V505Applies to: HD and PD | |
| Professional guideline | ||||||
| Iron: TSAT and ferritin | For HD patients on IV iron, check TSAT (transferrin saturation), ferritin and hemoglobin every 1 to 3 months, or more often when something changes.The guideline's PD and non-dialysis wording differs (at least every 3 months for people not on HD treated with iron). | Every 1 to 3 monthsFrom the start of IV iron | Professional guidelineprofessional guideline | HD (in-center and home) | Where it says so · applies toKDIGO Anemia 2026, Executive summary, iron monitoring (CKD G5HD on IV iron)Applies to: HD (in-center and home) | |
| Calcium and phosphate | In CKD G5D (KDIGO's stage for kidney failure on dialysis), check serum calcium and phosphate every 1 to 3 months. | Every 1 to 3 monthsFrom the start of dialysis (CKD G5D) | Professional guidelineprofessional guideline | HD and PD | Where it says so · applies toKDIGO CKD-MBD 2017, Chapter 3.1, reasonable monitoring intervals (Not Graded)Applies to: HD and PD | |
| PTH | In CKD G5D, check PTH (parathyroid hormone) every 3 to 6 months. | Every 3 to 6 monthsFrom the start of dialysis (CKD G5D) | Professional guidelineprofessional guideline | HD and PD | Where it says so · applies toKDIGO CKD-MBD 2017, Chapter 3.1, reasonable monitoring intervals (Not Graded)Applies to: HD and PD | |
| Alkaline phosphatase | In CKD G4 to G5D, check alkaline phosphatase every 12 months, or more often when PTH is elevated. | Every 12 monthsFrom CKD G4 onward | Professional guidelineprofessional guideline | HD and PD | Where it says so · applies toKDIGO CKD-MBD 2017, Chapter 3.1, reasonable monitoring intervals (Not Graded)Applies to: HD and PD | |
| Hepatitis C | Screen in-center HD patients for hepatitis C on starting or transferring in, then every 6 months. The federal regulation expressly leaves hepatitis C screening out of what it adopts.For PD and home HD the guideline suggests screening at the start (1.1.3) and sets no 6-month clock. | Every 6 monthsFrom the start of in-center HD | Professional guidelineprofessional guideline | In-center HD | Where it says so · applies toKDIGO Hepatitis C 2022, Recommendations 1.1.2 and 1.2.1 42 CFR 494.30(a)(1)(i), the exceptionApplies to: In-center HD | |
| HbA1c (diabetes) | For patients with diabetes, HbA1c twice a year is reasonable, up to four times a year if the target isn't met or therapy changes. The guideline adds that HbA1c is less reliable in dialysis patients. | Twice a year; up to 4 timesFrom a diabetes diagnosis | Professional guidelineprofessional guideline | HD and PD | Where it says so · applies toKDIGO Diabetes 2022, Practice Points 2.1.1 and 2.1.2Applies to: HD and PD | |
| Lipid panel | Measure lipids at the initial evaluation. Follow-up measurement isn't required for most patients. | Once, at initial evaluationFrom the initial evaluation | Professional guidelineprofessional guideline | HD and PD | Where it says so · applies toKDIGO Lipids 2013, Recommendations 1.1 and 1.2Applies to: HD and PD | |
| House practice | ||||||
| Monthly chemistry panel | A monthly chemistry panel. No regulation, survey guidance or guideline sets a monthly clock for the panel itself.Calcium is the exception to watch: QIP's Hypercalcemia reporting measure counts the patient-months a calcium value is reported (through payment year 2028). | Monthly, by facility customFrom the facility's lab calendar | House practicehouse practice | HD and PD | No outside source | Where it says so · applies toNo outside sourceApplies to: HD and PD |
| B12 and folate | A routine B12 and folate draw. The anemia and mineral guidelines read for this page set no calendar for it; when it's drawn is the facility's choice. | None | House practicehouse practice | HD and PD | No outside source | Where it says so · applies toNo outside sourceApplies to: HD and PD |
Where it can break
Break A: Between lab calendar and draw
House rows and federal floors look the same on the calendar.
Who feels it: Staff asked to defend a practice, and the leaders deciding whether it can change.
How it shows up: A practice nobody can source, kept or dropped on habit: "we've always done it this way."
What catches it: A calendar that marks each row by who sets its clock, as the table above does, shows which rows are house practice.
Break B: Between plan of care and EQRS submission Fails silently
The value is in the chart but not submitted before the EQRS window closes.
Who feels it: The facility.
How it shows up: Missing patient-months count against reporting measures. For payment year 2026, the Hypercalcemia measure scores the percentage of patient-months for which the facility reported an uncorrected calcium value, and a lower total score can reduce Medicare payment two years later.
What catches it: A monthly comparison of charted values with EQRS submissions, before the window closes, shows a value that was never submitted.
The path
The path as a list, step by step
- 1
Lab calendar
Break A: The schedule → Nursing staff
- 2
Draw
The sample → Laboratory
- 3
Result
The value → Interdisciplinary team
- 4
Plan of care
Break B, fails silently: The value, again → Facility data staff
- 5
EQRS submission
Submitted data → CMS (Waits for the year to close)
- 6
QIP scoring
The total performance score → Medicare Administrative Contractor (Paid out the next year)
- 7
Payment adjustment
What each step's record proves, and what it doesn't
| Step | Who | Proves | Doesn't prove | Rule |
|---|---|---|---|---|
| 1. Lab calendar | Facility leadershipMonthly floors | The facility has a schedule. | Which rows are federal requirements and which are guidance or house practice. | |
| 2. Draw | Nursing staffTreatment day (HD); collection day (PD) | A sample was taken. | That a result came back or was read. | |
| 3. Result | LaboratoryDays | A value exists. | That anyone acted on it. | RequiredThe facility must provide, or make available, laboratory services from a lab meeting the federal laboratory requirements (42 CFR 494.130).1 |
| 4. Plan of care | Interdisciplinary teamMonthly | The team has what it needs to adjust care. | That the value reached CMS. | RequiredAdequacy is assessed on an ongoing basis (494.80(c)); the team must provide the care needed to reach a clinically appropriate hemoglobin, measured at least monthly (494.90(a)(4)).1 |
| 5. EQRS submission | Facility data staffAbout 2 months after the month | CMS has the value. | That the care itself was right. | |
| 6. QIP scoring | CMSThe year after the draw | How the facility compares with the program's standards. | How any one patient is doing. | RequiredCalendar year 2024 performance sets payment year 2026 payment.7 |
| 7. Payment adjustment | Medicare Administrative ContractorTwo years after the draw | What the facility was paid. | Which month's missing data cost the points. |
What this page can't tell you
- How a PD program adapts the hepatitis B calendar. The adopted CDC document was written for in-center hemodialysis; that's local policy, and this page doesn't set it.1
- Which measures QIP scores in a given year. They change by payment year: from payment year 2027 Kt/V splits into adult and pediatric HD and PD measures, and from 2029 the calcium measure gives way to phosphorus.16,17
- Whether your state adds lab requirements. State rules aren't covered here.
Next
- Is this required, or is it just how we've always done it?
- How does a treatment become a payment?
- Dialysis adequacy: every line at every level
- Anemia: every line at every level
- The lab calendar: every line at every level
- Hepatitis B and C testing: every line at every level
- Mineral metabolism: every line at every level
Sources
- 42 CFR Part 494 (§§ 494.20-494.180)42 CFR Part 494 · read at the issuer · checked 11 Nov 2026
- State Operations Manual, Appendix H: Guidance to Surveyors, ESRD Facilities (Rev. 246)CMS Pub. 100-07, Transmittal 246 (issued, effective and implemented 2026-08-17), SOM Appendix H Parts I-III · read at the issuer · checked 11 Nov 2026
- KDIGO Anemia in CKD Guideline (2026)Kidney Int. 2026;109(1S) · read at the issuer · checked 11 Nov 2026
- KDIGO CKD-MBD Guideline (2017 Update)Kidney Int Suppl. 2017;7(1) · read at the issuer · checked 11 Nov 2026
- KDIGO Clinical Practice Guideline for Hepatitis C in CKD (2022)Kidney Int. 2022;102(6S) · read at the issuer · checked 11 Nov 2026
- KDIGO Clinical Practice Guideline for Diabetes Management in CKD (2022)Kidney Int. 2022;102(5S) · read at the issuer · checked 11 Nov 2026
- ESRD QIP PY2026 fact sheetCMS ESRD QIP PY2026 fact sheet · read at the issuer · checked 11 Nov 2026
- EQRS clinical data submission deadlines for CY2025 data (MyCROWNWeb)MyCROWNWeb, EQRS Clinical Data Submission Deadlines for CY 2025 Data · secondary · checked 5 Nov 2026
- 42 CFR 413.177 and 413.17842 CFR 413.177(a); 413.178 · read at the issuer · checked 11 Nov 2026
- KDIGO Clinical Practice Guideline for Lipid Management in CKD (2013)Kidney Int Suppl. 2013;3(3) · read at the issuer · checked 11 Nov 2026
- KDIGO and NKF-KDOQI (the guideline bodies)KDIGO (kdigo.org); NKF-KDOQI (kidney.org) · read at the issuer · checked 14 Jul 2026
- CMS EQRS (End-Stage Renal Disease Quality Reporting System)CMS EQRS / mycrownweb.org · read at the issuer · checked 14 Jul 2026
- CDC MMWR 2001;50(RR-05)—Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis PatientsMMWR 2001;50(RR-05):18-28 · read at the issuer · checked 14 Jul 2026
- ESRD Quality Incentive Program (CMS)CMS ESRD QIP · secondary · checked 14 Nov 2026
- Medicare Claims Processing Manual (Pub. 100-04), Chapter 8, Rev. 13740CMS Pub. 100-04, Ch. 8 (Rev. 13740, issued 2026-04-17), sections 10.4, 10.6, 20.3 and the claim-completion instructions · read at the issuer · checked 11 Nov 2026
- ESRD QIP PY2027 fact sheet (updated)CMS ESRD QIP PY2027 program details · read at the issuer · checked 11 Nov 2026
- CY 2027 ESRD PPS, AKI and ESRD QIP final rule (CMS-1846-F)91 FR 68736 (October 30, 2026), FR Doc. 2026-22194; effective January 1, 2027 · read at the issuer · checked 11 Nov 2026
https://middlemolecule.com/connections/why-we-draw-these-labs/